Integra LifeSciences Reports First Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Oppenheimer Downgrades Integra LifeSciences (IART) to Perform
May 7, 2024 6:09 AM EDTOppenheimer analyst Steven Lichtman downgraded Integra LifeSciences (NASDAQ: IART) from Outperform to Perform.
The analyst comments "Following an announced delay in manufacturing restart at IART's Boston facility, we are downgrading IART shares from Outperform to Perform and removing our $51 price target. As a... More
Integra LifeSciences (IART) PT Lowered to $26 at BofA Securities
May 7, 2024 5:38 AM EDTBofA Securities analyst Craig Bijou lowered the price target on Integra LifeSciences (NASDAQ: IART) to $26.00 (from $42.00) while maintaining a Underperform rating.
The analyst comments "The new findings from the Boston facility audit are the latest in a series of setbacks... More
